Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
European Journal of Medicinal Chemistry|November 7, 2025
Structural insights into frog skin-derived cyclic peptides as selective matriptase inhibitorsAgata Gitlin-Domagalska, Malihe Hassanzadeh, Aleksandra Helbik-Maciejewska, et al.Frontiers in Cardiovascular Medicine|August 28, 2023
Apelin prevents diabetes-induced poor collateral vessel formation and blood flow reperfusion in ischemic limbStéphanie Robillard, Kien Trân, Marie-Sophie Lachance, et al.The Journal of Biological Chemistry|April 4, 2026
Biosensor-Guided Discovery of Peptide Inhibitors Targeting the Ribosomal Protein uS5-PDCD2 Chaperone InteractionZabih Mir Hassani, Frédérique Goulet, Duc Tai Nguyen, et al.Free Radical Biology & Medicine|June 29, 2023
Conundrum of dehydroascorbic acid and homocysteine thiolactone reaction products: Structural characterization and effect on peptide and protein N-homocysteinylationGhizlane Loubane, Gabriel Robert, Syed Benazir Firdaus, et al.European Journal of Medicinal Chemistry|February 21, 2017
Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acidsCatherine St-Georges, Antoine Désilets, François Béliveau, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 20, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potencyAlexandre Joushomme, Antoine Désilets, William Champagne, et al.Biochimica Et Biophysica Acta. General Subjects|November 7, 2025
Structural characterization of a L-dehydroascorbic acid-L-homocysteine thiolactone reaction product: Intracellular formation in neuronal cellsGhizlane Loubane, Gabriel Robert, Syed Benazir Firdaus, et al.ACS Pharmacology & Translational Science|July 15, 2026
Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point MutationMathis Richard, Beatrice Louis, Marco F Taddio, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2021
Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analogMagali Chartier, Michael Desgagné, Marc Sousbie, et al.Biorxiv : the Preprint Server for Biology|September 11, 2024
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potencyAlexandre Joushomme, Antoine Désilets, William Champagne, et al.Pageof 7